Jeremy L. Stigall - Mar 6, 2023 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Role: GM, Biologics & Drug Delivery
Signature: /s/ Richard F. Mattern by Power of Attorney for Jeremy L. Stigall
Stock symbol: CLPT
Transactions as of: Mar 6, 2023
Transactions value $: $0
Form type: 4
Date filed: 3/8/2023, 03:51 PM
Previous filing: Feb 23, 2023
Next filing: Jun 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLPT	Stock Option (Right to Buy)	Award	$0	+14.8K		$0.00	14.8K	Mar 6, 2023	Common Stock	14.8K	$8.10	Direct	F1
transaction	CLPT	Restricted Stock Units	Award	$0	+44.4K		$0.00	44.4K	Mar 6, 2023	Common Stock	44.4K		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.
F2	Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.
F3	The restricted stock units vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.